EAM Investors’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-38,538
Closed -$1.16M 270
2025
Q3
$1.16M Buy
+38,538
New +$835K 0.13% 185
2023
Q4
Sell
-111,417
Closed -$5.09M 238
2023
Q3
$5.09M Buy
111,417
+19,255
+21% +$893K 0.98% 3
2023
Q2
$3.8M Sell
92,162
-23
-0% -$755 0.7% 15
2023
Q1
$2.86M Sell
92,185
-72,917
-44% -$2.35M 0.56% 45
2022
Q4
$3.32M Sell
165,102
-144,538
-47% -$3.09M 0.69% 25
2022
Q3
$4.37M Buy
+309,640
New +$4.17M 0.95% 7
2022
Q1
Sell
-230,146
Closed -$5.57M 271
2021
Q4
$5.57M Sell
230,146
-186,617
-45% -$3.65M 0.91% 5
2021
Q3
$5.69M Buy
+416,763
New +$2.99M 0.96% 4
2017
Q3
Sell
-263,019
Closed -$986K 292
2017
Q2
$986K Buy
263,019
+140,910
+115% +$595K 0.16% 198
2017
Q1
$587K Buy
+122,109
New +$460K 0.09% 280

Other funds holding AEHR

EAM Investors's AEHR Position: Q4 2025 in Review

EAM Investors sold out of Aehr Test Systems (AEHR) in Q4 2025, closing a stake of 38,538 shares — an estimated $1.16M sold.

EAM Investors first reported a position in AEHR in Q1 2017 and held it in 10 quarters. The position peaked at $5.69M in Q3 2021. 150 funds tracked by Wall St. Rank hold AEHR as of Q4 2025.

  • EAM Investors reported no remaining Aehr Test Systems position as of Q4 2025 after selling out during the quarter.
  • EAM Investors sold 38,538 Aehr Test Systems shares in Q4 2025, an estimated $1.16M.
  • EAM Investors first reported a position in Aehr Test Systems in Q1 2017 and held it in 10 quarters.
  • EAM Investors's Aehr Test Systems position peaked at $5.69M in Q3 2021.
  • 150 funds tracked by Wall St. Rank held Aehr Test Systems as of Q4 2025.

Based on EAM Investors's 13F filing for Q4 2025, filed 12 Feb 2026.